Bayer Sues Vaccine Makers Over Alleged Patent Infringement

Bayer has filed lawsuits against Pfizer, BioNTech, Moderna, and Johnson & Johnson, accusing them of using mRNA technology developed by Monsanto in the 1980s. The lawsuits seek monetary damages but do not aim to block vaccine production.

洞察:
Bayer AG has initiated a series of patent infringement lawsuits against four major pharmaceutical companies, alleging unauthorized use of mRNA stabilization technology originally developed by Monsanto in the 1980s. The lawsuits, filed on January 6, 2026, target Pfizer Inc. , BioNTech SE , Moderna Inc. , and Johnson & Johnson , and seek unspecified monetary damages without attempting to halt vaccine production.
The legal action was taken in two separate federal courts in the United States USUS, with lawsuits against Pfizer, BioNTech, and Moderna filed in Delaware, and a separate suit against Johnson & Johnson filed in New Jersey. Bayer's claims focus on the alleged misuse of mRNA technology, which was initially developed to enhance crop resilience but has since been adapted for use in COVID-19 vaccines.
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。